ELOX (Eloxx Pharmaceuticals) Insider Ownership: 23.17 % (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ELOX Eloxx Pharmaceuticals Inc ELOX
17 GF Score
Price $15.00
! 1 Warning Sign
View Full Analysis

What is Eloxx Pharmaceuticals Insider Ownership?

Eloxx Pharmaceuticals ELOX +8.77% 17 Insider Ownership is 23.17 % as of Sep. 05, 2026. GuruFocus rates ELOX with a GF Score™ of 17/100. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Eloxx Pharmaceuticals's insider ownership is 23.17%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Eloxx Pharmaceuticals's Institutional Ownership is 84.38%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Eloxx Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 88.36%.

Eloxx Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for Eloxx Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eloxx Pharmaceuticals Insider Ownership Chart

Eloxx Pharmaceuticals Historical Data

The historical data trend for Eloxx Pharmaceuticals can be seen below:

2022-02-28 2022-03-31 2022-04-30 2022-05-31 2022-06-30 2022-07-31 2022-08-31 2022-09-30 2022-10-31 2022-11-30
Insider Ownership 23.28 23.17 23.17 23.17 23.17 23.17 23.17 23.17 23.17 23.17
ELOX
17GF Score
Eloxx Pharmaceuticals Inc ELOX
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eloxx Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 23.17 % mean?
Eloxx Pharmaceuticals (ELOX) has a Insider Ownership of 23.17 % as of Sep. 05, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Eloxx Pharmaceuticals and its competitors.
Is Eloxx Pharmaceuticals' Insider Ownership too high?
Eloxx Pharmaceuticals' current Insider Ownership is 23.17 %. Overall, Eloxx Pharmaceuticals has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Eloxx Pharmaceuticals' Insider Ownership compare to TCRX and MCRB?
Eloxx Pharmaceuticals' Insider Ownership of 23.17 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Eloxx Pharmaceuticals and its competitors. Eloxx Pharmaceuticals's current Insider Ownership is 23.17 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eloxx Pharmaceuticals stock overvalued right now?
Eloxx Pharmaceuticals (ELOX) has a current Insider Ownership of 23.17 %. The current Insider Ownership is 23.17 %. Eloxx Pharmaceuticals' overall GF Score™ is 17/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Eloxx Pharmaceuticals (ELOX), the current Insider Ownership is 23.17 % as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eloxx Pharmaceuticals Business Description

Other Exchanges J36:Germany
Address 10 Court Street, P.O. Box 274, Arlington, MA, USA, 02476
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
17GF Score

Get the complete analysis for ELOX

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.00
Price